Therapeutic SINERGY for modulation of gut inflammation and microbiome dysregulation in colitis
We engineered biomarker-sensing SINERGY consortia that report and alleviate inflammatory bowel disease symptoms in the DSS-induced colitis mouse model. This project analyzed the microbiome of mouse feces in the Control, DSS-PBS, DSS-WT, and DSS-TH groups.